A clear comparison
Wolverine combines BPC-157 and TB-500. KLOW contains those two ingredients plus GHK-Cu and KPV. Compare composition first, then total size, price and documentation.
The differences at a glance
Reference facts and current product information are separate below. On a small screen, swipe within the table; keyboard users can focus it and scroll with the arrow keys.
| Compare | KLOW | Wolverine |
|---|---|---|
| Reference · material class | Four-peptide blend | Two-peptide blend |
| Reference · identity and composition | GHK-Cu + BPC-157 + TB-500 + KPV. Individual component quantities are unconfirmed. | BPC-157 + TB-500. Individual component quantities are unconfirmed. |
| Reference · research question | Skin, repair & inflammation | BPC-157 + TB-500 |
| Reference · evidence and limitations | The listed 80 mg is the nominal total blend amount. Individual component quantities are not confirmed in this catalogue. Studies on separate ingredients do not establish the effect of this exact combination. | The listed 20 mg is the nominal total blend amount. The ingredient split is not confirmed here, so it should not be assumed to contain 10 mg of each peptide. |
| Reference · source papers | See the ingredient-specific sources and limitations in the comparison. | See the ingredient-specific sources and limitations in the comparison. |
| Product · current sizes and prices | 80 mg · $129.99 In stock | 10 mg · $79.99 In stock20 mg · $119.99 In stock |
| Product · current stock | In stock | In stock |
| Product · supplied specification | Confirm form, identity and specification for the selected size. A field not reported remains unconfirmed. Product specifications | Confirm form, identity and specification for the selected size. A field not reported remains unconfirmed. Product specifications |
| Product · matching lot records | No matching published record. Check Lab Results | No matching published record. Check Lab Results |
| Product · information and availability | View available options | View available options |
Product figures come from the current WooCommerce listing in the store currency. Package milligrams are nominal material amounts, not doses. No report for another sample or lot is substituted for a matching record.
The ingredient difference
Both blends include BPC-157 and TB-500 in their confirmed component lists. KLOW additionally includes GHK-Cu and KPV, connecting the name with skin and inflammatory-signalling topics as well as tissue-repair discussions. Those category links describe the interests around the ingredients. They do not establish the effect of either exact blend.
Why total milligrams can mislead
Wolverine is listed as 20 mg nominal total and KLOW as 80 mg nominal total. Neither listing currently confirms the split between ingredients. A higher total does not tell you how much more of a shared component is present. Even a price-per-total-milligram comparison cannot answer the price per milligram of BPC-157 inside either blend.
What useful documentation would show
A clear blend specification identifies every component, the amount of each and the basis on which those amounts are expressed. A matching batch report should identify the same sample and explain the analytical method. When those details are absent, leave the comparison open instead of filling the gap with assumed ratios. The product pages retain the fuller specification discussion.
How to keep the comparison practical
Use the table for the named ingredients, current total sizes and current product prices. Use the individual product links to review the longer material descriptions. If your question concerns a single ingredient, compare its standalone listing as well. This separates three different decisions: understanding the topic, checking composition and evaluating the available product documentation.
Common questions
Is KLOW just a larger Wolverine?
No. KLOW has two additional named ingredients and an unconfirmed component ratio.
Are the ingredient ratios equal?
The confirmed catalogue does not establish equal ratios for either blend.
Original sources
These papers support the specific mechanisms or study models discussed above. They do not test the current Peptide Place catalogue batches.
- Chang et al. (2011): BPC-157 and tendon fibroblast experiments ↗
- Maquart et al. (1988): GHK-Cu and collagen synthesis in cultured fibroblasts ↗
- Dalmasso et al. (2008): KPV in intestinal inflammation models ↗
Continue exploring
KLOW: current options and full overview →

